Used in research as a synthetic intermediate for alkaloid derivatives, particularly in the development of compounds with potential neuroactive properties. Shows interest in pharmacological studies for central nervous system modulation due to structural similarity to tetrahydroisoquinoline alkaloids. Investigated for possible applications in treating neurological disorders, including Parkinson’s disease and depression, through dopamine receptor interaction. Also employed in the design of novel ligands for receptor binding studies. Not used in commercial products or industrial applications; limited to laboratory and experimental settings.